14-3-3 sigma and 14-3-3 zeta plays an opposite role in cell growth inhibition mediated by transforming growth factor-beta 1

Molecules and Cells

Volumn 29, Issue 3, 2010, Pages 305-309

  Hong, Hye Young ^a   Jeon, Woo Kwang ^a   Bae, Eun Jin ^b   Kim, Shin Tae ^b   Lee, Ho Jae ^b   Kim, Seong Jin ^b   Kim, Byung Chul ^a  

^a Kangwon National University   (South Korea)

^b Gachon University College of Medicine   (South Korea)

Author keywords

14 3 3 ; 14 3 3 ; Cell growth inhibition; Phosphorylation of Smad3 linker region; TGF 1

Indexed keywords

PROTEIN 14 3 3; PROTEIN 14 3 3 ZETA; PROTEIN P15; RAS PROTEIN; SMAD3 PROTEIN; SMALL INTERFERING RNA; STRATIFIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BREAST EPITHELIUM; CANCER CELL; CANCER RESISTANCE; CELL CYCLE ARREST; CELL GROWTH; CELL TRANSFORMATION; CONTROLLED STUDY; EPITHELIUM CELL; GROWTH INHIBITION; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; REPORTER GENE;

14-3-3 PROTEINS; ANIMALS; BINDING SITES; CELL CYCLE; CELL DIVISION; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, VIRAL; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P27; EPITHELIAL CELLS; FEMALE; GENE KNOCKDOWN TECHNIQUES; GENES, RAS; MAMMARY GLANDS, ANIMAL; MICE; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RNA INTERFERENCE; RNA, SMALL INTERFERING; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

EID: 77953537998     PISSN: 10168478     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10059-010-0037-8     Document Type: Article

References (29)

1. Bajpai, U., Sharma, R., Kausar, T., Dattagupta, S., Chattopadhayay, T.K., and Ralhan, R. (2008). Clinical significance of 14-3-3 zeta in human esophageal cancer. Int. J. Biol. Markers 23, 231-237.
2. Bhowmick, N.A., Ghiassi, M., Aakre, M., Brown, K., Singh, V., and Moses, H.L. (2003). TGF-beta-induced RhoA and p160ROCK activation is involved in the inhibition of Cdc25A with resultant cell-cycle arrest. Proc. Natl. Acad. Sci. USA 100, 15548-15523.
3. Chelli, B., Lena, A., Vanacore, R., Pozzo, E.D., Costa, B., Rossi, L., Salvetti, A., Scatena, F., Ceruti, S., Abbracchio, M.P., et al. (2004). Peripherial benzodiazepine receptor ligands: mitochon-drial transmembrane potential depolarization and apoptosis induction in rat C6 glioma cells. Biochem. Pharmacol. 68, 125-134.
4. Chomczynski, P., and Sacchi, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
5. Datto, M.B., Frederick, J.P., Pan, L., Borton, A.J., Zhuang, Y., and Wang, X.F. (1999). Targeted disruption of Smad3 reveals an essential role in transforming growth factor beta-mediated signal transduction. Mol. Cell. Biol. 19, 2495-2504.
6. Derynck, R., and Zhang, Y.E. (2003). Smad-dependent and Smadindependent pathways in TGF-beta family signaling. Nature 425, 465-471.
7. Hermeking, H., Lengauer, C., Polyak, K., He, T.C., Zhang, L., Thiagalingam, S., Kinzler, K.W., and Vogelstein, B. (1997). 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol. Cell 1, 3-11.
8. Massagué, J., Blain, S.W., and Lo, R.S. (2000). TGF-beta signaling in growth control, cancer, and heritable disorders. Cell 103, 295-309.
9. Kowalik, T.F. (2002). Smad about E2F. TGF-beta repression of cmyc via a Smad7/E2F/p107 complex. Mol. Cell 10, 7-8.
10. Li, Z., Zhao, J., Du, Y., Park, H.R., Sun, S.Y., Bernal-Mizrachi, L., Aitken, A., Khuri, F.R., and Fu, H. (2008). Down-regulation of 14-3-3zeta suppresses anchorage-independent growth of lung cancer cells through anoikis activation. Proc. Natl. Acad. Sci. USA 105, 162-167.
11. Matsuura, I., Denissova, N.G., Wang, G., He, D., Long, J., and Liu, F. (2004). Cyclin-dependent kinases regulate the antiproliferative function of Smads. Nature 430, 226-231.
12. Matsuura, I., Wang, G., He, D., and Liu, F. (2005). Identification and characterization of ERK MAP kinase phosphorylation sites in Smad3. Biochemistry 44, 12546-12553.
13. Matsuzaki, K., Kitano, C., Murata, M., Sekimoto, G., Yoshida, K., Uemura, Y., Seki, T., Taketani, S., Fujisawa, J., and Okazaki, K. (2009). Smad2 and Smad3 phosphorylated at both linker and COOH-terminal regions transmit malignant TGF-beta signal in later stage of human malignant cancer. Cancer Res. 69, 5321-5330.
14. Maxwell, S.A., Li, Z., Jaya, D., Ballard, S., Ferrell, J., and Fu, H. (2009). 14-3-3zeta mediates resistance of diffuse large B cell lymphoma to an anthracycline-based chemotherapeutic regimen. J. Biol. Chem. 284, 22379-22389.
15. Mils, V., Baldin, V., Goubin, F., Pinta, I., Papin, C., Waye, M., Ey-chene, A., and Ducommun, B. (2000). Specific interaction between 14-3-3 isoforms and the human CDC25B phosphatase. Oncogene 19, 1257-1265.
16. Moreira, J.M., Ohlsson, G., Rank, F.E., and Celis, J.E. (2005). Down-regulation of the tumor suppressor protein 14-3-3sigma is a sporadic event in cancer of the breast. Mol. Cell Proteomics 4, 555-569.
17. Morrison, D.K. (2009). The 14-3-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer development. Trends Cell Biol. 19, 16-23.
18. Munday, A.D., Berndt, M.C., and Mitchell, C.A. (2000). Phosphoinositide 3-kinase forms a complex with platelet membrane glycoprotein Ib-IX-V complex and 14-3-3zeta. Blood 96, 577-584.
19. Pear, W.S., Nolan, G.P., Scott, M.L., and Baltimore, D. (1993). Production of high-titer helper free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90, 8392-8396.
20. Rich, J.N., Zhang, M., Datto, M.B., Bigner, D.D., and Wang, X.F. (1999). Transforming growth factor-beta-mediated p15(INK4B) induction and growth inhibition in astrocytes is SMAD3 dependent and a pathway prominently altered in human glioma cell lines. J. Biol. Chem. 274, 35053-35058.
21. Robson, C.N., Gnanapragasam, V., Byrne, R.L., Collins, A.T., and Neal, D.E. (1999). Transforming growth factor-beta1upregulates p15, p21 and p27 and blocks cell cycling in G1 in human prostate epithelium. J. Endocrinol. 160, 257-266.
22. Sekimoto, G., Matsuzaki, K., Yoshida, K., Mori, S., Murata, M., Seki, T., Matsui, H., Fujisawa, J., and Okazaki, K. (2007). Reversible Smad-dependent signaling between tumor suppression and oncogenesis. Cancer Res. 67, 5090-5096.
23. Siegel, P.M., Shu, W., and Massagué, J. (2003). Mad upregulation and Id2 repression accompany transforming growth factor (TGF)-mediated epithelial cell growth suppression. J. Biol. Chem. 278, 35444-35450.
24. Song, K., Wang, H., Krebs, T.L., and Danielpour, D. (2006). Novel roles of Akt and mTOR in suppressing TGF-beta/ALK5-mediated Smad3 activation. EMBO J. 25, 58-69.
25. Takahashi, Y. (2003). The 14-3-3 proteins: gene, gene expression, and function. Neurochem. Res. 28, 1265-1273.
26. Wakefield, L.M., and Roberts, A.B. (2002). TGF-beta signaling: positive and negative effects on tumorigenesis. Curr. Opin. Genet. Dev. 12, 22-29.
27. Wicks, S.J., Lui, S., Abdel-Wahab, N., Mason, R.M., and Chantry, A. (2000). Inactivation of smad-transforming growth factor beta signaling by Ca(2+)-calmodulin-dependent protein kinase II. Mol. Cell. Biol. 20, 8103-8111.
28. Yang, X., Letterio, J.J., Lechleider, R.J., Chen, L., Hayman, R., Gu, H., Roberts, A.B., and Deng, C. (1999). Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta. EMBO J. 18, 1280-1291.
29. Yang, H., Wen, Y.Y., Zhao, R., Lin, Y.L., Fournier, K., Yang, H.Y., Qiu, Y., Diaz, J., Laronga, C., and Lee, M.H. (2006). DNA damage-induced protein 14-3-3 sigma inhibits protein kinase B/Akt activation and suppresses Akt-activated cancer. Cancer Res. 66, 3096-3105.